SQLite Web: event_store.db

Update row 932 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-07T23:23:54.391414+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:57e4ad942ab86ca5","evidence_event_ids":["evt_ebc92ae922b2"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","as_of":"2026-04-07T23:23:54.391414+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","company":"Vir Biotechnology, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","article_chars":2006,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_2b6973232c90f5f7","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","content_type":"text/plain","enriched_at":"2026-04-07T23:33:10.232136+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","source_event_id":"evt_ebc92ae922b2","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"a87590aad4ad6495","kind":"sec_filing","published_at":"20260406","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-06","2026-02-23","2026-02-24"],"entities":[{"asset_class":"equity","name":"Vir Biotechnology, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Marianne De Backer","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Fidelity Brokerage Services LLC","relevance":"medium","symbol":"","type":"broker_or_agent"}],"event_type":"listing","information_gaps":["The cleaned text does not clearly state the total number of shares to be sold across all entries or the exact \u201csale\u201d vs \u201cvesting\u201d classification for each line item beyond the presence of \u201cRestricted Stock Vesting\u201d and the tax-obligation note.","No explicit prior-known state is provided in the prompt, so the \u201cwhat changed vs prior known state\u201d cannot be determined from the supplied text alone.","The filing\u2019s full table/fields are not fully structured in the cleaned text (e.g., whether each dated entry is a sale, vesting, or both, and the exact price/consideration fields for each)."],"key_facts":["SEC accession number: 0001959173-26-002789; Form type: 144; filed as of date: 20260406.","Subject company: Vir Biotechnology, Inc.; CIK/Central Index Key: 0001706431; SEC file number: 001-39083.","Reporting owner: Marianne De Backer; listed as Officer Director; address in Pasadena, CA.","The filing references NASDAQ common stock and includes a transaction date of 04/06/2026.","The filing includes a note: \u201cSale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.\u201d","The document includes additional entries dated 02/23/2026 and 02/24/2026 with quantities and prices (as shown in the cleaned text)."],"numeric_claims":[{"label":"Filing date (filed as of)","value":"2026-04-06"},{"label":"Transaction date referenced","value":"2026-04-06"},{"label":"Additional dates referenced","value":"2026-02-23; 2026-02-24"},{"label":"Quantity/amount shown for 04/06/2026 entry","value":"72559 (as shown)"}],"primary_claim":"A Form 144 for Vir Biotechnology, Inc. was filed on 2026-04-06 for common stock transactions by Marianne De Backer (Officer/Director), including sales to cover tax obligations from vested equity award settlement.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Vir Biotechnology, Inc. filed a Form 144 on 2026-04-06 related to common stock held by reporting owner Marianne De Backer, including sales tied to vested equity and tax obligations.","topics":["SEC Form 144","insider sale","restricted stock vesting","tax obligation","common stock"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Vir Biotechnology, Inc. \u00b7 Filed 20260406","ticker":"VIR","tickers":["VIR"],"title":"VIR filed 144","url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel